Quantinno Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
12,847
+2,240
| +21% | +$282K | 0.01% | 1145 |
|
|
2025
Q1 | $1.17M | Buy |
10,607
+6,644
| +168% | +$735K | 0.01% | 1109 |
|
|
2024
Q4 | $541K | Buy |
3,963
+1,724
| +77% | +$235K | 0.01% | 1208 |
|
|
2024
Q3 | $258K | Buy |
2,239
+448
| +25% | +$51.6K | ﹤0.01% | 1313 |
|
|
2024
Q2 | $247K | Buy |
1,791
+154
| +9% | +$21.2K | ﹤0.01% | 1212 |
|
|
2024
Q1 | $226K | Buy |
+1,637
| New | +$226K | ﹤0.01% | 1156 |
|